These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 29704382

  • 1. Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.
    Nadaraja RND, Sthaneshwar P, Razali N.
    Malays J Pathol; 2018 Apr; 40(1):33-39. PubMed ID: 29704382
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome.
    Hahn S, Kuehnel W, Tan S, Kramer K, Schmidt M, Roesler S, Kimmig R, Mann K, Janssen OE.
    Clin Chem Lab Med; 2007 Apr; 45(2):202-7. PubMed ID: 17311509
    [Abstract] [Full Text] [Related]

  • 3. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S, Dittrich R, Binder H, Kajaia N, Hoffmann I, Maltaris T, Beckmann MW, Mueller A.
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [Abstract] [Full Text] [Related]

  • 4. Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism.
    Al Kindi MK, Al Essry FS, Al Essry FS, Mula-Abed WA.
    Oman Med J; 2012 Nov; 27(6):471-4. PubMed ID: 23226817
    [Abstract] [Full Text] [Related]

  • 5. The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents.
    Khashchenko E, Uvarova E, Vysokikh M, Ivanets T, Krechetova L, Tarasova N, Sukhanova I, Mamedova F, Borovikov P, Balashov I, Sukhikh G.
    J Clin Med; 2020 Jun 11; 9(6):. PubMed ID: 32545404
    [Abstract] [Full Text] [Related]

  • 6. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots.
    Barth JH, Field HP, Yasmin E, Balen AH.
    Eur J Endocrinol; 2010 Mar 11; 162(3):611-5. PubMed ID: 20008514
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of different diagnostic methods for assessment of hyperandrogenism in young women with hirsutism.
    Chanukvadze D, Kristesashvili J.
    Georgian Med News; 2011 Nov 11; 11(200):25-9. PubMed ID: 22201076
    [Abstract] [Full Text] [Related]

  • 8. Correlation of biochemical markers and clinical signs of hyperandrogenism in women with polycystic ovary syndrome (PCOS) and women with non-classic congenital adrenal hyperplasia (NCAH).
    Chanukvadze D, Kristesashvili J, Kvashilava N.
    Iran J Reprod Med; 2012 Jul 11; 10(4):307-14. PubMed ID: 25246891
    [Abstract] [Full Text] [Related]

  • 9. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.
    Yetim A, Yetim Ç, Baş F, Erol OB, Çığ G, Uçar A, Darendeliler F.
    J Clin Res Pediatr Endocrinol; 2016 Sep 01; 8(3):288-97. PubMed ID: 27125339
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG, Guo Y, Ma LA, Xing J, Sun RF, Zhu W.
    J Cosmet Dermatol; 2018 Jun 01; 17(3):511-517. PubMed ID: 28940857
    [Abstract] [Full Text] [Related]

  • 11. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.
    Yue CY, Lu LK, Li M, Zhang QL, Ying CM.
    PLoS One; 2018 Jun 01; 13(8):e0203129. PubMed ID: 30153296
    [Abstract] [Full Text] [Related]

  • 12. Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study.
    Pinola P, Piltonen TT, Puurunen J, Vanky E, Sundström-Poromaa I, Stener-Victorin E, Ruokonen A, Puukka K, Tapanainen JS, Morin-Papunen LC.
    J Clin Endocrinol Metab; 2015 Sep 01; 100(9):3400-7. PubMed ID: 26192874
    [Abstract] [Full Text] [Related]

  • 13. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF, Li X, Zhu MW.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct 01; 41(10):684-8. PubMed ID: 17199924
    [Abstract] [Full Text] [Related]

  • 14. Testosterone and bioavailable testosterone help to distinguish between mild Cushing's syndrome and polycystic ovarian syndrome.
    Pall ME, Lao MC, Patel SS, Lee ML, Ghods DE, Chandler DW, Friedman TC.
    Horm Metab Res; 2008 Nov 01; 40(11):813-8. PubMed ID: 18819057
    [Abstract] [Full Text] [Related]

  • 15. A prospective study of anti-mullerian hormone and other ovarian and adrenal hormones in adult female acne.
    Bansal P, Sardana K, Arora P, Khurana A, Garga UC, Sharma L.
    Dermatol Ther; 2020 Nov 01; 33(6):e13974. PubMed ID: 33185003
    [Abstract] [Full Text] [Related]

  • 16. Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia.
    Cho LW, Kilpatrick ES, Jayagopal V, Diver MJ, Atkin SL.
    Clin Endocrinol (Oxf); 2008 Mar 01; 68(3):390-4. PubMed ID: 17888022
    [Abstract] [Full Text] [Related]

  • 17. The free androgen index is inaccurate in women when the SHBG concentration is low.
    Keevil BG, Adaway J, Fiers T, Moghetti P, Kaufman JM.
    Clin Endocrinol (Oxf); 2018 May 01; 88(5):706-710. PubMed ID: 29405348
    [Abstract] [Full Text] [Related]

  • 18. Endocrinological markers for assessment of hyperandrogenemia in hirsute women.
    Mueller A, Cupisti S, Binder H, Hoffmann I, Kiesewetter F, Beckmann MW, Dittrich R.
    Horm Res; 2007 May 01; 67(1):35-41. PubMed ID: 17019078
    [Abstract] [Full Text] [Related]

  • 19. Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies.
    Escobar-Morreale HF, Asunción M, Calvo RM, Sancho J, San Millán JL.
    Eur J Endocrinol; 2001 Nov 01; 145(5):619-24. PubMed ID: 11720881
    [Abstract] [Full Text] [Related]

  • 20. The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome.
    Yang Y, Ouyang N, Ye Y, Hu Q, Du T, Di N, Xu W, Azziz R, Yang D, Zhao X.
    Reprod Biomed Online; 2020 Oct 01; 41(4):734-742. PubMed ID: 32912651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.